TDP43 Protein Links Neurodegeneration and Cancer
Analysis based on 8 articles · First reported Mar 06, 2026 · Last updated Mar 16, 2026
This medical breakthrough by Houston Methodist could significantly impact the biotechnology and pharmaceutical sectors by opening new avenues for drug development targeting neurodegenerative diseases and cancer. Companies involved in DNA repair mechanisms or related therapies may see increased investor interest.
Researchers at Houston Methodist have discovered that the protein TDP43, previously linked to neurodegenerative conditions like dementia and ALS, also plays a critical role in controlling DNA mismatch repair. This repair system corrects errors during DNA replication. The findings suggest that abnormal levels of TDP43 can harm neurons and destabilize the genome, increasing the risk of cancer. This discovery establishes a novel link between neurodegeneration and cancer, potentially reshaping scientific understanding and leading to new therapeutic strategies. Lead investigator Muralidhar L. Hegde emphasized the broad implications for diseases where TDP43 goes awry. The research, primarily funded by the United States===National Institute of Neurological Disorders and Stroke and the United States===National Institute on Aging, was published in Nucleic Acids Research.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard